FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3204359864> ?p ?o ?g. }

• W3204359864 endingPage "1108" @default.
• W3204359864 startingPage "1108" @default.
• W3204359864 abstract "4716 Arsenic Trioxide (ATO) has been shown to be highly active against acute promyelocytic leukemia (APL) and has activity in several other diseases including multiple myeloma. While initial clinical trials in both APL and myeloma have suggested that melarsoprol results in greater dose-limiting toxicities than ATO, it is generally accepted that organic arsenicals are less toxic than inorganic arsenicals. Consequently, organic arsenicals that kill myeloma cells could be clinically more effective than ATO. Recently, organic arsenicals were synthesized that have EC50s similar to ATO against cell line panels but are > 10-fold less toxic. One such compound, ZIO-101 is in phase I studies. Therefore we compared the ability of ZIO-101 and ATO to kill four myeloma cell lines that display differential sensitivity to ATO. The RPMI 8226 and U266 are less sensitive than the KMS11 and MM.1s lines. When dose response curves were generated comparing ATO and ZIO-101 at 24, 48 and 72 hrs we found that the U266, KMS11 and MM.1s lines were consistently 1-3 fold less sensitive to ZIO-101 than to ATO. However if one considers the number of atoms of elemental arsenic/molecule of drug, these data would suggest that the ability of these drugs to kill MM cell lines is similar. In contrast the 8226 line was more sensitive to ZIO-101. Additionally we have previously reported that ATO induces caspase-dependent and -independent cell death in a cell specific fashion in these lines. We found a similar pattern of caspase dependence with ZIO-101 where BocD-FMK, a caspase inhibitor, completely blocks ZIO-101-induced killing of U266, partially blocks killing of MM.1s and KMS11 and has no effect no killing of 8226. These data suggest that the downstream components of the death signaling pathway induced by ZIO-101 and ATO are similar. In contrast, initial responses to these drugs differ. We and others have reported that glutathione (GSH) is a critical regulator of ATO-induced cell death and have utilized ascorbic acid (AA) as a GSH depleting agent both in vitro as well as clinically. We therefore tested the effects of GSH depletion on ZIO-101 induced cell death in MM cell lines. Using concentrations of ATO and ZIO-101 that had similar activity, we determined the effects of both an inhibitor of GSH synthesis (BSO) as well as AA that can transient deplete GSH. BSO sensitized all 4 cell lines to both agents, however it was much more effective at sensitizing cells to ATO than to ZIO-101. Moreover while AA could sensitize cells to ATO, it actually protected cells from cell death induced by ZIO-101. Taken together these data suggest that ZIO-101 has activity against myeloma cells although factors that determine the potency of this compound are different than those for ATO. This may reflect differences in either metabolism or mechanism of action. Thus resistance to one form of arsenic does not preclude the use of another. A phase I/II study of ZIO-101 in myeloma is planned." @default.
• W3204359864 created "2021-10-11" @default.
• W3204359864 creator A5029496318 @default.
• W3204359864 creator A5046430988 @default.
• W3204359864 creator A5050227848 @default.
• W3204359864 creator A5073182906 @default.
• W3204359864 creator A5088125558 @default.
• W3204359864 date "2006-04-15" @default.
• W3204359864 modified "2023-09-24" @default.
• W3204359864 title "In vitro activity of a novel organic arsenical (S-dimethylarseno-glutathione, ZIO-101) against multiple myeloma" @default.
• W3204359864 hasPublicationYear "2006" @default.
• W3204359864 type Work @default.
• W3204359864 sameAs 3204359864 @default.
• W3204359864 citedByCount "0" @default.
• W3204359864 crossrefType "journal-article" @default.
• W3204359864 hasAuthorship W3204359864A5029496318 @default.
• W3204359864 hasAuthorship W3204359864A5046430988 @default.
• W3204359864 hasAuthorship W3204359864A5050227848 @default.
• W3204359864 hasAuthorship W3204359864A5073182906 @default.
• W3204359864 hasAuthorship W3204359864A5088125558 @default.
• W3204359864 hasConcept C185592680 @default.
• W3204359864 hasConcept C190283241 @default.
• W3204359864 hasConcept C202751555 @default.
• W3204359864 hasConcept C2780386689 @default.
• W3204359864 hasConcept C31573885 @default.
• W3204359864 hasConcept C502942594 @default.
• W3204359864 hasConcept C54355233 @default.
• W3204359864 hasConcept C55493867 @default.
• W3204359864 hasConcept C81885089 @default.
• W3204359864 hasConcept C86803240 @default.
• W3204359864 hasConceptScore W3204359864C185592680 @default.
• W3204359864 hasConceptScore W3204359864C190283241 @default.
• W3204359864 hasConceptScore W3204359864C202751555 @default.
• W3204359864 hasConceptScore W3204359864C2780386689 @default.
• W3204359864 hasConceptScore W3204359864C31573885 @default.
• W3204359864 hasConceptScore W3204359864C502942594 @default.
• W3204359864 hasConceptScore W3204359864C54355233 @default.
• W3204359864 hasConceptScore W3204359864C55493867 @default.
• W3204359864 hasConceptScore W3204359864C81885089 @default.
• W3204359864 hasConceptScore W3204359864C86803240 @default.
• W3204359864 hasLocation W32043598641 @default.
• W3204359864 hasOpenAccess W3204359864 @default.
• W3204359864 hasPrimaryLocation W32043598641 @default.
• W3204359864 hasRelatedWork W1513990729 @default.
• W3204359864 hasRelatedWork W1535524422 @default.
• W3204359864 hasRelatedWork W1868101689 @default.
• W3204359864 hasRelatedWork W2007037758 @default.
• W3204359864 hasRelatedWork W2012144964 @default.
• W3204359864 hasRelatedWork W2035767729 @default.
• W3204359864 hasRelatedWork W2040903736 @default.
• W3204359864 hasRelatedWork W2113796216 @default.
• W3204359864 hasRelatedWork W2216341447 @default.
• W3204359864 hasRelatedWork W2401206126 @default.
• W3204359864 hasRelatedWork W2410412992 @default.
• W3204359864 hasRelatedWork W2411096837 @default.
• W3204359864 hasRelatedWork W2411109058 @default.
• W3204359864 hasRelatedWork W2505350742 @default.
• W3204359864 hasRelatedWork W2518333365 @default.
• W3204359864 hasRelatedWork W2551167066 @default.
• W3204359864 hasRelatedWork W2588950547 @default.
• W3204359864 hasRelatedWork W2885197186 @default.
• W3204359864 hasRelatedWork W2911532461 @default.
• W3204359864 hasRelatedWork W1648648517 @default.
• W3204359864 hasVolume "66" @default.
• W3204359864 isParatext "false" @default.
• W3204359864 isRetracted "false" @default.
• W3204359864 magId "3204359864" @default.
• W3204359864 workType "article" @default.